The role of herpes simplex virus type 1 (HSV-1) glycoprotein E (gE) in the induction of multinucleate cell (syncytium) formation was investigated using monoclonal antibodies and agE deletion mutant, R7023. We found that monoclonal antibodies directed against gE blocked HSV-l-induced syncytium formation in human ce~ls. R7023 also failed to induce syncytium formation in tissue culture cells. The results indicate that gE, in addition to glycoproteins B, D, H and the gene sequence located between 0.732 and 0-745 map units, is involved in cell fusion. Thus, this important biological property appears to be regulated by several HSV-1 gene products.
Envelope glycoproteins of a variety of animal viruses are essential for adsorption, penetration and, in some instances, cell-to-cell fusion resulting in the formation of multinucleate cells or syncytia. Viral glycoproteins are transported to the plasma membrane and presumably mediate cell fusion, an event which leads to cell-to-cell spread of infection (Hoggan & Roizman, 1959; Hoggan et al., 1960; Lodmell & Notkins, 1974) . The exact role of glycosylation in this important biological process is not well understood. It has been reported that glycosylation of the fusioninducing product synthesized by Mason-Pfizer monkey virus is not required for syncytium formation (Chatterjee et al., 1981) . However, with Newcastle disease virus and herpes simplex virus type 1 (HSV-1), the ability to induce multinucleate cells can be prevented if glycosylation is blocked (Gallaher et al., 1973) . The specific glycoprotein(s) involved in HSV-l-induced cell fusion is unclear. Although several cell surface glycoproteins, gB, gC, gD, gE, gG, gH and gI, have been identified in HSV-infected cells (Baucke & Spear, 1979; Eberle & Courtney, 1980; Marsden et al., 1984; Roizman et al., 1984; Gompels & Minson, 1986; Longnecker et al., 1987) , the exact biological functions of these glycoproteins are not completely understood (Roizman & Batterson, 1985) . By employing temperature-sensitive mutants, the ionophore monensin and transfection experiments, several workers have demonstrated that at least one of these glycoproteins, gB, is required for HSV-induced cell fusion but other gene products may be required as well (Manservigi et al., 1977; Kousoulas et al., 1983; All et al., 1987; Cai et al., 1988) . In fact, monoclonal antibodies against gD and gH block HSV-induced cell fusion which suggests that gD and gH are also involved in this process (Noble et al., 1983 ; Gompels & Minson, 1986) . The specific roles of these glycoproteins in cell-to-cell fusion are, however, not known. In this communication, we report that monoclonal antibodies against gE inhibited cell fusion induced by HSV-1 in human fibroblast cells. In addition, agE deletion mutant, R7023, failed to induce multinucleate cell formation in tissue culture. Thus, in addition to other gene products, it appears that gE is involved in cell fusion by HSV-1.
Monoclonal antibodies against HSV-1 gE were isolated and characterized as described previously (Koga et al., 1986; Metcalf et al., 1988) . Fig. 1 (a) (Koga et al., 1986) . Lane 1, immunoprecipitation with supernatant from hybridoma Fd200; lane 2, Fd 172. (b) The experimental procedure was same as in (a), except that the cells were labelled with [3H]glucosamine (40 Ci/mmol; ICN Pharmaceuticals) and immunoprecipitated with clone Fd200. The gE precursor is pgE. Fig. 2 . Specificity of the monoclonal antibodies against gE. F-and R7023-infected cell lysates were processed for immunoblotting as described previously (Chatterjee et al., 1985) using monoclonal antibodies against gB, gD and gE. Lanes 1, 3 and 5, F-infected cell lysates; lanes 2, 4 and 6, R7023-infected cell lysates. Blot (a) was reacted with monoclonal antibody against gE; blot (b) was reacted with monoclonal antibody against gB, and blot (c) with monoclonal antibody against gD. distinct bands corresponding to the Mr of mature gE (80K) and its precursor pgE (69K) were identified. The positions of these two bands were identical when immunoprecipitation profiles obtained with other anti-gE monoclonal antibodies (provided by Dr L. Pereira) were compared. In order to confirm that these monoclonal antibodies were directed against glycosylated polypeptides, a RIP with [3H]glucosamine-labelled, HSV-l-infected HEp-2 cell lysates was performed. Two distinct bands at the same positions as observed with [3SS]methionine-labelled cell lysates indicated that the monoclonal antibodies were directed against two glycosylated polypeptides of 80K and 69K (Fig. 1 b) . The specificity of these monoclonal antibodies was confirmed by using R7023, provided by Dr B. Roizman (Longnecker & Roizman, 1986) . African green monkey kidney (B-SC-1) cells were infected with either R7023 or strain F of HSV- 1. Infected cell lysates were processed for immunoblotting as previously described (Chatterjee et al., 1985) . The resulting blots were reacted with monoclonal antibodies against gE and, finally, with 125i_labelled Protein A. As shown in Fig. 2 (a) , the specificity of the monoclonal antibodies for gE was confirmed. It should be noted that R7023 also lacks the a sequences located at the junction between the L and S components, an origin of viral DNA synthesis and the ~47 gene, although gE is the only glycoprotein deleted (Longnecker & Roizman, 1986) . To demonstrate the presence of other major glycoproteins in the mutant-infected cells, identical blots were reacted with monoclonal antibodies against gB and gD and with 125I-labelled Protein A; this clearly showed the presence of gB and gD in cells infected with R7023 ( Fig. 2b and c) .
None of these anti-gE monoclonal antibodies had significant neutralizing activity in the absence of complement. Clones Fd172 and Fd200 showed complement-dependent neutralizing activities, with titres of 500 and 300 respectively (Metcalf et al., 1988) . Nevertheless, these antibodies blocked the multinucleate cell formation induced by HSV-1 as described below. In brief, human foreskin fibroblast cells, grown in a 96-well microtitre plate were adsorbed with different concentrations (m.o.i. of 5, 1, 0-5 and 0.1) of the MP strain of HSV-1 for 1 h. Ninety min after this initial adsorption period, ascites fluids (approx. 50 ~tg of mouse IgG/ml) were added to the infected cells which were then observed at 16 h post-infection after staining with May-Griinwald-Giemsa as previously described (Chatterjee & Hunter, 1979) , for their ability to block cell fusion. The number of syncytia per well in each group was determined and the percentage inhibition of syncytium formation was calculated. The result of this experiment (Table 1) indicated that these monoclonal antibodies prevented the ability of HSV-1 to cause fusion in human cells. A threefold dilution of the antibodies showed a proportionate increase in syncytium formation (data not shown). Almost identical results were obtained with the anti-gE monoclonal antibodies provided by Dr L. Pereira (data not shown). In addition to these anti-gE monoclonal antibodies, some of the anti-gB and anti-gD monoclonal antibodies inhibited HSV-l-induced syncytium formation in parallel experiments (Table 1) . However, monoclonal antibodies against gC (clone Fd8) did not significantly block multinucleate cell formation which ruled out the possibility of the presence of a common fusion-inhibitory (toxic) factor in these monoclonal antibody preparations.
In order to confirm fusion inhibition by monoclonal antibodies, R7023 was studied for the induction of cell-to-cell fusion. B-SC-1 cells were infected with serial dilutions (m.o.i. of 10, 1.0, 0-1 and 0-01) of strain F or R7023. We used monkey kidney cells because the mutant grew well in this cell line but did not in human fibroblast cells. Cells were stained 16 h post-infection as before, and the number of syncytium-forming units/ml was determined. This mutant, unlike strain F, did not induce any fusion of monkey cells in tissue culture (Table 2) . Furthermore, to demonstrate that the absence of multinucleate cell formation induced by R7023 was not related to gB and gD expression on the cell surface, the following experiment was performed. Monkey kidney cells were infected with R7023 or F and processed for solid-phase radioimmunoassay 16 h post-infection using monoclonal antibodies against gB, gD and gE. The procedure for this assay was adapted from Chatterjee et al. (1981) without fixing the cells. The result of this experiment (Fig. 3 a) demonstrated the presence of only gB and gD on the surface of the mutantinfected cells whereas the surface of F-infected cells expressed gB, gD and gE as expected (Fig.  3 b) . Thus, in spite of the presence of gB and gD on the surface of R7023-infected cells, this mutant did not induce syncytium formation. The inability of R7023 to induce cell fusion was not due to a reduced quantity of progeny virions, as the amount of virus released from the mutantinfected cells was almost the same as the amount of input virions (data not shown).
Although several major species of HSV-1-specified glycoproteins, designated gB, gC, gD, gE, gG, gH and gI, have been identified, their specific biological functions have not been precisely determined; gB, gD and gH have been shown to be important for cell fusion activity (see above for references). In this report, we demonstrated that, in addition to these three, gE is involved in HSV-l-induced multinucleate cell formation. We found that monoclonal antibodies directed against gE prevented HSV-l-mediated syncytium formation in human fibroblast cells. Furthermore, the gE deletion mutant R7023 failed to induce multinucleate cell formation in tissue culture, suggesting that gE is involved in cell fusion. Since previous reports have indicated that gB, gD and gH are involved in cell fusion, it is likely that this property is regulated by several distinct gene products of HSV-1. The biological importance of gE is also supported by recent observations from this laboratory that anti-gE monoclonal antibodies prevent stromal keratitis and protect mice against encephalitis (Metcalf et al., 1988) .
During past years, a great deal of effort has been devoted to the study of the role of glycoproteins in HSV-l-induced cell fusion. The mechanism of HSV-l-induced multinucleate cell formation might be analogous to that proposed for Sendai virus-induced cell fusion. The fusion process in the latter case consists of two steps, a binding step mediated by HN glycoproteins, and the fusion step mediated by F glycoproteins (Choppin et al., 1981) . It should be noted that gE is known to be responsible for the induction of Fc-binding activity on virusinfected cells (Baucke & Spear, 1979) . Since HSV-1 glycoproteins B, D, E and H might play a role in cell fusion, it will be of interest to pinpoint the specific polypeptide(s) involved in the binding activity and in the actual fusion event. However, at this time the possibility of involvement of other gene products in this biological process can not be ruled out. In fact it has been reported that the gene sequence located between 0.732 and 0.745 map units of HSV-1 (KOS strain) is also associated with cell fusion (Debroy et al., 1985) .
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